News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CoreWeave's bonds and CDS moved into crisis, sending its equity to near-term lows.
  • Enterprise value remains substantially higher than market cap, signaling potential undervaluation.
  • GPU-driven cloud demand still supports CoreWeave's long-term growth runway.
  • Analysts propose buying the pullback with a defined stop and a long-term horizon tied to refinancing progress.
  • Credit panic increases CoreWeave's refinancing risk and near-term share volatility.
  • Widened bond and CDS spreads may curb lenders' appetite for cloud-sector credits.

Latest Articles

QTREX Quantum Reports First Half 2026 Financial Results

QTREX Quantum Reports First Half 2026 Financial Results

QTREX Quantum Ltd., listed on Nasdaq as QTEX, reported record first half 2026 revenue of $1.55 million, a 438% increase year-over-year, driven by its AME and Quantum segment following a recent acquisition. The company launched its proprietary RF dielectric material INSU300 and has secured validation deployments with government and defense organizat…

McDonald's on Sale: Buy the Dividend King After the Panic

McDonald's on Sale: Buy the Dividend King After the Panic

McDonald's has been sold down to near its 52-week low despite stable cash flow, a 3% yield, and an attractive P/E. The pullback looks driven by flow and short-term competitive chatter, not a structural earnings reset. This trade targets a mean reversion to $285 with a tight stop under the 52-week low — favorable risk/reward for a mid-term swing tra…

TTEC Unveils CARES, a New Quality Intelligence Metric That Measures What Customers Actually Experience

TTEC Unveils CARES, a New Quality Intelligence Metric That Measures What Customers Actually Experience

TTEC Holdings, Inc. introduced TTEC CARES, a new AI-powered quality intelligence metric that analyzes 100% of customer interactions to measure resolution, effort, and sentiment, providing companies with deeper insights into customer experience beyond traditional quality assurance methods. This innovation promises improved operational performance an…

SEALSQ Leverages NIST FIPS 140-3 Level 3 Validation to Accelerate Government, Critical-Infrastructure and Post-Quantum Hardware-Security Programs; Provides Updated Certification and Commercialization Timetable

SEALSQ Leverages NIST FIPS 140-3 Level 3 Validation to Accelerate Government, Critical-Infrastructure and Post-Quantum Hardware-Security Programs; Provides Updated Certification and Commercialization Timetable

SEALSQ Corp announced that its VaultIC408 secure element platform has achieved NIST FIPS 140-3 Level 3 validation, a significant hardware-security certification recognized globally. This enables the company to expand commercially within U.S. government, defense, critical infrastructure, and other sectors requiring rigorous cryptographic protection.…

FBS Global Limited Announces 1-for-10 Share Consolidation

FBS Global Limited Announces 1-for-10 Share Consolidation

FBS Global Limited approved a one-for-ten reverse stock split of its ordinary shares to increase the per-share price and comply with Nasdaq's minimum bid price of $1.00 for continued listing. Post consolidation, the share count will reduce while shareholder proportional ownership largely remains the same. The company focuses on high-specification c…

Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform

Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform

Autonomix Medical, Inc. has been granted European Patent No. EP 4 233 700 B1 for its innovative systems assessing autonomic nervous system activity through ocular neural activity monitoring. This patent enhances the company's global intellectual property portfolio protecting its precision nerve-targeted platform technologies, supporting various neu…

MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits

MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits

MindWave Innovations, a subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has signed a 12-month agreement with Singapore-based AQUAE Holdings to develop and operate AQUAEChain, a blockchain-based platform managing insured ALCI Credits for ecosystem finance. The platform combines technology and environmental methodologies to prov…

Liberty Defense Expands U.S. Distribution Footprint with New Agreement with VMI Security for HEXWAVE™

Liberty Defense Expands U.S. Distribution Footprint with New Agreement with VMI Security for HEXWAVE™

Liberty Defense Holdings Ltd. has entered a non-exclusive distribution agreement with VMI Security to expand the U.S. sales of its HEXWAVE walk-through security screening system. This partnership will leverage VMI's established customer base and sales infrastructure to accelerate adoption of Liberty's AI-powered detection technology across key secu…

Cloudastructure Management Discusses Enterprise Growth Strategy at Water Tower Research Insights Conference

Cloudastructure Management Discusses Enterprise Growth Strategy at Water Tower Research Insights Conference

Cloudastructure's management presented their growth strategy at the Water Tower Research Insights Conference, focusing on expanding deployments with major U.S. multifamily property managers, entering new vertical markets such as construction and logistics, and enhancing recurring subscription revenue. The company aims to scale commercial operations…

Polar Power CEO Arthur Sams Converts $614,700 of Debt Into Preferred Equity, Strengthening Balance Sheet

Polar Power CEO Arthur Sams Converts $614,700 of Debt Into Preferred Equity, Strengthening Balance Sheet

Polar Power's CEO Arthur Sams converted $614,700 of debt owed by the company into Series A Convertible Preferred shares, improving the company's balance sheet and shareholder equity. This move supports the company's efforts to regain compliance with Nasdaq listing requirements and signals confidence in future growth across multiple sectors includin…

HCW Biologics Announces Pricing of $1.5 Million Private Placement

HCW Biologics Announces Pricing of $1.5 Million Private Placement

HCW Biologics Inc., a clinical-stage biopharmaceutical company, announced the pricing of a $1.5 million private placement with an existing stockholder. The financing involves the issuance of pre-funded warrants and common stock purchase warrants subject to stockholder approval. Proceeds will support ongoing clinical trials of HCW9302 and advance st…

SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy

SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy

SeaStar Medical celebrated Dr. H. David Humes’ receipt of the University of Michigan's Distinguished University Innovator of the Year award for developing the Selective Cytopheretic Device (SCD) therapy. The therapy, commercialized as QUELIMMUNE, is FDA-approved for critically ill pediatric patients with acute kidney injury and sepsis, showing sign…

IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

IMUNON, Inc. presented encouraging results from its Phase 2 OVATION 2 study of IMNN-001, demonstrating a 14.7-month median overall survival improvement in advanced ovarian cancer patients. The company highlighted the favorable safety profile of its IL-12 DNA plasmid immunotherapy and announced strong enrollment progress in the ongoing Phase 3 OVATI…

Tencent at a Discount - Position for an AI and Cloud Re-rate

Tencent at a Discount - Position for an AI and Cloud Re-rate

Tencent (TCEHY) is trading near $55.92 with a market cap of roughly $508.5B and a P/E of 15.5. AI-driven spending across games, cloud and fintech + a large payments footprint create a material re-rating opportunity. I lay out an actionable long: entry $55.50, stop $52.50, target $70.00 for a mid-term (45 trading days) trade, with clear catalysts an…

SkyAI Comments on Annual Meeting Results

SkyAI Comments on Annual Meeting Results

SkyAI, Inc. acknowledges significant shareholder concerns reflected in the 2026 Annual Meeting voting results. The Board and management are committed to thoroughly engaging with shareholders and evaluating necessary actions related to capital allocation, corporate governance, strategic direction, and shareholder communications to reduce the company…